Tag: AstraZeneca
UK-based drugmaker AstraZeneca to acquire Alexion
British pharmaceutical giant behind the most anticipated Oxford COVID-19 vaccine, AstraZeneca has decided to acquire U.S. drugmaker Alexion Pharmaceuticals for $39 billion.
The move, the...
AstraZeneca-Sputnik V COVID-19 vaccines prepare for a combined trial
In collaboration with the Russian Gamaleya Research Institute, the Russian Direct Investment Fund (RDIF) and R-Pharm, UK-based drugmaker AstraZeneca will conduct a clinical trial...
Oxford COVID-19 vaccine faces tough questions after manufacturing error reveal
After acknowledging a manufacturing error, University of Oxford and drugmaker AstraZeneca face mounting questions about their COVID-19 vaccine trial results.
Although an announcement by Oxford...
Oxford’s COVID-19 vaccine gives 70% protection: Trial results up expectations
A large-scale study shows that the coronavirus vaccine developed by the University of Oxford in collaboration with drugmaker AstraZeneca prevents 70 percent of people...
Phase 3 COVID-19 vaccine trial data by Christmas; Oxford researchers
While conversing on the latest results from the ongoing late-stage trials of AstraZeneca-Oxford COVID-19 vaccine candidate, Dr. Andrew Pollard, an expert in pediatric infection...
Oxford COVID-19 vaccine shows positive immune response in elderly
The mid-stage trial results of a COVID-19 vaccine candidate developed by AstraZeneca Plc and Oxford University shows a strong immune response in older people.
The...
India to get 100mn Oxford vaccine shots by December: Serum Institute
The world's largest vaccine producer, Serum Institute of India, is ramping up production of the COVID-19 shot from Oxford-AstraZeneca, hoping to have 100 million...
Emergency approval for Oxford vaccine may happen by Christmas: Reports
Prof. Adrian Hill, Founder-Director of the University of Oxford's Jenner Institute is upbeat about the possibility of gathering emergency approvals for their COVID-19 vaccine...
